Volume : 11, Issue : 06, June – 2024
Title:
A REVIEW ON MULTIPLE SCLEROSIS ACTIVITY OF PLANTS FROM THE ZINGIBEBRACEAE FAMILY
Authors :
Miss.Amrutha. B, Mrs. Savitha Mol G.M, Dr.Prasobh.G. R
Abstract :
Multiple sclerosis (MS), the most prevalent neurological disability, is an autoimmune mediated disorder that affects the central nervous system (CNS) and often leads to severe physical or cognitive incapacitation as well as neurological problems in young adults. Multifocal zones of inflammation due to focal T-lymphocytic and macrophage infiltrations, and oligodendrocyte death are the primary causes of myelin sheath de- struction that result in the formation of CNS plaques composed of inflammatory cells and their products, demyelinated and transected axons, and astrogliosis in both white and gray matter. Subtypes of MS are considered important not only for prognosis but also for treatment decisions and include: relapsing remitting MS (RRMS), primary progressive MS (PPMS), secondary progressive MS (SPMS), and progressive relapsing MS (PRMS). Induced symptoms include problems with walking, weakness, stiffness, and trouble with balance. lants have been used as medicines throughout history. Indeed, studies of wild animals show that they also instinctively eat certain plants to treat themselves for certain illnesses. Medicinal plants are widely and successfully used on every continent. In Asia, the practice of herbal medicine is extremely well established and documented. Multiple sclerosis is a chronic inflammatory disease that affects the brain and the spinal cord. Environmental factors such as vitamin D levels, viral infections, obesity, and smoking can contribute to MS development. Genetic factors also have a significant role in MS formation as several genes can increase susceptibility to this disease. The herbal plants showing strong activity on Multiple sclerosis in zingiberace family such as zingiber officinal and curcuma loga.
Keywords: Multiple sclerosis, Zingiberace family, Astrocytes, Medicine, Animals
Cite This Article:
Please cite this article in press Amrutha. B et al, A Review On Multiple Sclerosis Activity Of Plants From The Zingibebraceae Family.,Indo Am. J. P. Sci, 2024; 11 (06).
Number of Downloads : 10
References:
1. L J. DREWS, in Quest of tomorrow’s medicines (SPRINGER-VERLAG, New York 1999) pp.51- 68.F.J. MOORE, A History of Chemistry (McGraw-Hill, New York, 1918) pp. 212- 220.
2. Altman DG, Schulz KF, Egger M. Davidoff F. Lang T. Consort G (2001) The revised CONSORT statement for reporting randomized trials, explanation and elaboration. An Intern Med 134: 663-694. OMAIR A Selecting the appropriate study design for your research: Descriptive study design. J Health Spec 2015; 3:153-6
3. 3.CARNWELL, R, & DALY, W (2001), Strategies for the Construction of a Critical Review of the Literature. Nurse Education practice 1:57-63.
4. 4.Mahajan BK, “Methods in Biostatics”. JAYPEE brothers 1997; sixth edition; 168-185
5. 5.Drug Discovery and Evaluation: pharmacological assays/ H. Gerhard Vogel second edition pp. 948.
6. 6.Pereira S, Tettamanti M (2005) Ahimsa and alternatives the concept of the 4th R. The CPCSEA in India.
7. 7.OECD (2000) Guidance Documenton acute oral toxicity. Environmental health and safety monograph series on Testing and Assessment No 24.
8. 8.Dakhale GN, Hiware SK, Shinde AT, Mahatme MS. Basic biostatics for postgraduate students. Indian J Pharmacology 2012; 44:435-42.
9. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517. [PubMed] [Google Scholar]
10. Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Current neuropharmacology. 2011;9(3):409–416.
11. Allen IV, Kirk J. Demyelinating diseases. In: Adams JH. Ducher Lw, eds. Greenfields neuropathology, 5th ed. New York: Oxford Univ Press, 1992:447-510.
12. 12.Ellison GW, Myers LW, Mickey MR, et al. Clinical experience with azathioprine: the pros. Neurology. 1988; 38 (sup 2): 20-23.
13. 13.De Vries, G.H.; Bullene, A.I. Glial cell lines: an overview. Neurochem. Res., 2010, 35, 1978-2000.
14. National Research Council (2011), Guide for the care and use of laboratory animals. 8th edition. NIH Publication. Washington DC, US. Dept. of Health and Human Services.